Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
William D. Chey, Anthony Lembo, David P. Rosenbaum
The American Journal of Gastroenterology (2017) Vol. 112, Iss. 5, pp. 763-774
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Irritable bowel syndrome
Alexander C. Ford, Ami D. Sperber, Maura Corsetti, et al.
The Lancet (2020) Vol. 396, Iss. 10263, pp. 1675-1688
Open Access | Times Cited: 568
Mechanisms, Evaluation, and Management of Chronic Constipation
Adil E. Bharucha, Brian E. Lacy
Gastroenterology (2020) Vol. 158, Iss. 5, pp. 1232-1249.e3
Open Access | Times Cited: 426
An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation
Imran Aziz, William E. Whitehead, Olafur S. Palsson, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 14, Iss. 1, pp. 39-46
Open Access | Times Cited: 248
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis
Christopher J. Black, Elyse R. Thakur, Lesley A. Houghton, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1441-1451
Open Access | Times Cited: 210
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation
Lin Chang, Shahnaz Sultan, Anthony Lembo, et al.
Gastroenterology (2022) Vol. 163, Iss. 1, pp. 118-136
Open Access | Times Cited: 102
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Wilfried Müllens, Kevin Damman, Sebastiaan Dhont, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 730-741
Closed Access | Times Cited: 24
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
Christopher J. Black, Nicholas Burr, Eamonn M.M. Quigley, et al.
Gastroenterology (2018) Vol. 155, Iss. 6, pp. 1753-1763
Open Access | Times Cited: 144
New treatments and therapeutic targets for IBS and other functional bowel disorders
Magnus Simrén, Jan Tack
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 10, pp. 589-605
Closed Access | Times Cited: 126
Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria
Christopher J. Black, Yan Yiannakou, Lesley A. Houghton, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 2, pp. 392-398.e2
Open Access | Times Cited: 100
Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)
William D. Chey, Anthony Lembo, David P. Rosenbaum
The American Journal of Gastroenterology (2020) Vol. 115, Iss. 2, pp. 281-293
Open Access | Times Cited: 78
Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation
Xiaodan Shi, Yedong Hu, Bo Zhang, et al.
JCI Insight (2021) Vol. 6, Iss. 14
Open Access | Times Cited: 74
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Antonio Sircana, Franco De Michieli, Renato Parente, et al.
Pharmacological Research (2018) Vol. 144, pp. 390-408
Closed Access | Times Cited: 71
Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging
Giles Major, Kathryn Murray, G. Singh, et al.
Neurogastroenterology & Motility (2018) Vol. 30, Iss. 9
Open Access | Times Cited: 69
Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission
Maria Giuliana Vannucchi, Stefano Evangelista
Journal of Clinical Medicine (2018) Vol. 7, Iss. 1, pp. 4-4
Open Access | Times Cited: 66
A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles
Christopher J. Black, Yan Yiannakou, Elspeth Guthrie, et al.
The American Journal of Gastroenterology (2020) Vol. 116, Iss. 2, pp. 372-381
Open Access | Times Cited: 66
Chronic constipation: new insights, better outcomes?
Lawrence R. Schiller
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 11, pp. 873-882
Closed Access | Times Cited: 55
The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
Michelle Bosman, Sigrid Elsenbruch, Maura Corsetti, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 6, pp. 459-473
Open Access | Times Cited: 49
SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation
Peter M. Haggie, Onur Çil, Sujin Lee, et al.
JCI Insight (2018) Vol. 3, Iss. 14
Open Access | Times Cited: 49
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
David P. Rosenbaum, Andrew T. Yan, Jeffrey Jacobs
Clinical Drug Investigation (2018) Vol. 38, Iss. 4, pp. 341-351
Open Access | Times Cited: 48
Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)
William D. Chey, Anthony Lembo, Yang Yang, et al.
The American Journal of Gastroenterology (2020) Vol. 116, Iss. 6, pp. 1294-1303
Open Access | Times Cited: 48
Recent advances in understanding and managing chronic constipation
David O. Prichard, Adil E. Bharucha
F1000Research (2018) Vol. 7, pp. 1640-1640
Open Access | Times Cited: 47
Pharmacotherapy for Irritable Bowel Syndrome
Michael Camilleri, Alexander C. Ford
Journal of Clinical Medicine (2017) Vol. 6, Iss. 11, pp. 101-101
Open Access | Times Cited: 43
New advances in the treatment of paediatric functional abdominal pain disorders
Neha R. Santucci, Miguel Saps, Miranda A.L. van Tilburg
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 5, Iss. 3, pp. 316-328
Closed Access | Times Cited: 42
Existing and emerging therapies for managing constipation and diarrhea
Adil E. Bharucha, Mira M. Wouters, Jan Tack
Current Opinion in Pharmacology (2017) Vol. 37, pp. 158-166
Open Access | Times Cited: 41
Tenapanor: First Approval
Anthony Markham
Drugs (2019) Vol. 79, Iss. 17, pp. 1897-1903
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top